Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France

Blood

Volumn 99, Issue 11, 2002, Pages 3909-3915

  Mariette, Xavier ^a,b,c,d,e   Cazals Hatem, Dominique ^a,b,c,d,e   Warszawki, Josiane ^a,b,c,d,e   Liote, Frédéric ^a,b,c,d,e   Balandraud, Nathalie ^a,b,c,d,e   Sibilia, Jean ^a,b,c,d,e  

^a BICÊTRE HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c Fédération de Rhumatologie   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; FRANCE; HODGKIN DISEASE; HUMAN; INCIDENCE; LYMPHOMA; LYMPHOMA CELL; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0036624739     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.11.3909     Document Type: Article

References (43)

1. Lea AJ. An association between the rheumatic diseases and the reticuloses. Ann Rheum Dis. 1964;23:480-484.
2. Banks PM, Witrak GA, Conn DLM. Lymphoid neoplasia developing after connective tissue disease. Mayo Clin Proc. 1979;54:104-108.
3. Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985;78:29-32.
4. Kamel OW, Van de Rijn M, Weiss LM, et al. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med. 1993;328:1317-1321.
5. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943-1949.
6. Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment. Semin Arthritis Rheum. 1997;26:794-804.
7. Kamel OW, Van de Rijn M, Hanasono MM, Warnke RA. Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leuk Lymphoma. 1995;16:363-368.
8. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: Report of two cases. Arthritis Rheum. 1996;39:325-329.
9. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective study. Am J Med. 1995;99:276-281.
10. Bologna C, Picot MC, Jorgensen C, Viu P, Verdier R, Sany J. Study of eight cases of cancer in 426 rheumatoid patients treated with methotrexate. Ann Rheum Dis. 1997;56:97-102.
11. Kremer JM. Safety, efficacy and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: Follow-up after a mean of 13.3 years. Arthritis Rheum. 1997;40:984-985.
12. Weinblatt ME, Maier AL, Fraser PA, Coblyn JS. Long-term prospective study of methotrexate in rheumatoid arthritis: Conclusion after 132 months of therapy. J Rheumatol. 1998;25:238-242.
13. Wolfe F. Inflammatory activity, but not methotrexate or prednisone use predicts non-Hodgkin's lymphoma in rheumatoid arthritis: A 25-year study of 1,767 RA patients. Arthritis Rheum. 1998;41: S188.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
15. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
16. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966;26:1063-1083.
17. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
18. Bregeon C, Rolland D, Canonne F, Renier JC. Estimation de la prévalence de la polyarthrite rhumatoïde à partir d'une étude en milieu rhumatologique dans l'arrondissement d'Angers. [Prevalence estimate of rheumatoid arthritis based on a rheumatological study in Angers]. Rev Rheum. 1986;53:83-90.
19. Louvot J, Flipo RM, Le Dantec L, et al. Estimation de la prévalence de la polyarthrite rhumatoïde en France: Etude au sein de la communauté urbaine de Lille. [Prevalence estimate of rheumatoid arthritis in France: Study in the city of Lille]. Rev Rhum. 1996;10:824.
20. Saraux A, Guedes C, Allain J, et al. Prevalence or rheumatoid arthritis and spondyloarthropathy in Brittany, France. J Rheumatol. 1999;26:2622-2627.
21. Le Dantec L, Flipo RM, Louvot J, Coquerelle P, Duquesnoy B, Delcambre B. Prise en charge thérapeutique de la polyarthrite rhumatoïde dans une importante cohorte de malaces ambulatoires. [Treatment of rheumatoid arthritis in a large cohort of outpatients]. Rev Rhum. 1996;63:823.
22. Sany J, Dropsy R, Daurès JP. Cross-sectional epidemiological survey of rheumatoid arthritis patients seen in private practice in France: Descriptive results (1629 cases). Rev Rhum Eng Ed. 1998;65:462-470.
23. Ménégoz F, Chérié-Challine L, Grosclaude P, Jougla E. Le Cancer en France: Incidence et Mortalité: Situation en 1995: Evolution Entre 1975 et 1995. Edition DGS et Réseau FRANCIM. La Documentation Française, 1998.
24. Samuels SJ, Beaumont JJ, Breslow NE. Power and detectable risk or seven tests for standardized mortality ratios. Am J Epidemiol. 1991;133:1191-1197.
25. Royer B, Cazals-Hatern D, Sibilia J, et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90:766-775.
26. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood. 1997;90:776-782.
27. Mariette X. Lymphomas in patients with Sjögren's syndrome: Review of the literature and physiopathologic hypothesis. Leuk Lymphoma. 1999;33:93-99.
28. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:1218-1225.
29. Toussirot E, Wendling D, Tiberghien P, Luka J, Roudier J. Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp 110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis. 2000;59:533-538.
30. Gentile TC, Hadlock KG, Uner AH, et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol. 1998;101:507-512.
31. Loughran TP Jr, Zambello R, Ashley R, et al. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia. Blood. 1993;81:2723-2726.
32. Pellenz M, Zambello R, Semenzato G, Loughran TP Jr. Detection of Epstein-Barr virus by PCR analyses in lymphoproliferative disease of granular lymphocytes. Leuk Lymphoma. 1996;23:371-374.
33. Kamel OW, Holly EA, Van de Rijn M, Lele C, Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol. 1999;26:1676-1680.
34. Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: Nested case-control study. Br Med J. 1998;317:180-181.
35. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum. 2000;43:14-21.
36. Knecht H, Odermatt BF, Bachmann E, et al. Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without evidence of B or T cell clonality. Blood. 1991;78:760-767.
37. Kamel OW, Weiss LM, Van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996;20:1279-1287.
38. Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low-dose methotrexate. J Rheumatol. 1997;24:2035-2037.
39. Chevrel G, Berger F, Miossec P, et al. Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1999;42:1773-1776.
40. Moseley AC, Lindsley HB, Skikne BS, Tawfik O. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease. J Rheumatol. 2000;27:810-813.
41. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst. 1995;87:175-182.
42. Medeiros LJ, Greiner TC. Hodgkin's disease. Cancer. 1995;75:357-369.
43. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med. 1992;117:309-311.